Sunniva Inc (SNNVF) fair value: what the stock is really worth
As of Sep 21, 2026: fair value of Sunniva Inc $0.00, price $0.00, upside +0.0%, quality 32 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Sunniva Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands.
Show more
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
Stock analysis
Sunniva Inc (SNNVF) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Sunniva Inc reported revenue of $18.8M in FY2018 versus $0 in FY2014. Reported net income was −$29.0M in FY2018.
Key figures
Market cap $3.9K · EPS (TTM) $−7.88 · Net margin −143% · Return on equity −64.1% · Return on assets (EBIT) −51.4% · Operating margin −133% · Revenue (TTM) $35.0M · Revenue growth (YoY) +354%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades near its 52-week high.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at 0%, SNNVF screens cheaper than that median.
Fair Value models
Bear $0.0001Fair Value $0.0001Bull $0.0001
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.31/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2018 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 614 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Sunniva Inc Fair Value". https://www.fairvalue-calculator.com/stock/SNNVF
Frequently asked questions
Is Sunniva Inc (SNNVF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001, about +0% upside (fairly valued).
What is the fair value of SNNVF?
Our model-based fair value for Sunniva Inc is $0.0001 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.0001.
What is the quality score of SNNVF?
Sunniva Inc has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sunniva Inc (SNNVF)?
Our model-based price target is the fair value of $0.0001 (as of Sep 24, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Sunniva Inc stock forecast for 2026?
Our models put fair value at $0.0001, about +0% upside versus a price of $0.0001 (fairly valued). The calculation is refreshed regularly with new filings.
What is the revenue of Sunniva Inc (SNNVF)?
Sunniva Inc reported trailing-twelve-month revenue of about $35.0M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Sunniva Inc (SNNVF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sunniva Inc it is $0.0001 per share (as of Sep 24, 2026), against a price of $0.0001. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Sunniva Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, SNNVF trades below its calculated fair value: price $0.0001, fair value $0.0001, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SNNVF?
No. The price is what the market pays today ($0.0001); the fair value is what the company's own numbers justify ($0.0001). For Sunniva Inc the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sunniva Inc worth?
The market values Sunniva Inc at about $3.9K (market capitalisation, as of Sep 24, 2026). Per share that is $0.0001; our models calculate a fair value of $0.0001 per share.
How solid is the balance sheet of Sunniva Inc (SNNVF)?
Balance-sheet figures for Sunniva Inc (as of Sep 24, 2026): return on equity −64.1%, debt of 0.10 per unit of equity. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
Which stocks are comparable to Sunniva Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sunniva Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0001, calculated fair value $0.0001 (+0%), Quality Score 32/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SNNVF calculated?
We run Sunniva Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0001, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Sunniva Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sunniva Inc (SNNVF)?
The closing price on Sep 21, 2026 was $0.0001. Our model-based fair value is $0.0001, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sunniva Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Sunniva Inc
How large is the market capitalisation of Sunniva Inc (SNNVF)?
The market capitalisation of Sunniva Inc is $3.9K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Sunniva Inc (SNNVF)?
Earnings per share at Sunniva Inc are $−7.88. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sunniva Inc (SNNVF)?
The net margin of Sunniva Inc is −143% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sunniva Inc (SNNVF)?
The return on equity (ROE) of Sunniva Inc is −64.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sunniva Inc (SNNVF)?
On an EBIT basis the return on assets of Sunniva Inc is −51.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sunniva Inc (SNNVF)?
The operating margin of Sunniva Inc is −133% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sunniva Inc (SNNVF)?
Revenue at Sunniva Inc is growing +354% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Sunniva Inc (SNNVF) generate?
The free cash flow of Sunniva Inc is −$65.5M (fiscal year 2018). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Sunniva Inc (SNNVF) carry?
The net debt of Sunniva Inc is $21.5M (fiscal year 2018). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Sunniva Inc in the live analysis
One click puts Sunniva Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 24, 2026